Anti-oxidant Containing Nanostructured Lipid Carriers of Ritonavir: Development, Optimization, and In Vitro and In Vivo Evaluations

Medicine & Life Sciences

• Ritonavir 82%
• Antioxidants 47%
• Lipids 42%
• In Vitro Techniques 28%
• Pharmacokinetics 21%
• Drug Liberation 21%
• Excipients 16%
• Protease Inhibitors 14%
• Biological Availability 12%
• Pharmaceutical Preparations 11%
• Retroviridae Infections 10%
• Lopinavir 10%
• HIV 9%
• Differential Scanning Calorimetry 8%
• alpha-Tocopherol 8%
• Fourier Transform Infrared Spectroscopy 8%
• Emulsions 7%
• Particle Size 7%
• Buffers 6%
• Suspensions 6%
• Phosphates 6%
• Acquired Immunodeficiency Syndrome 5%
• Area Under Curve 5%
• Therapeutics 2%

Chemical Compounds

• Ritonavir 100%
• Antioxidant Agent 49%
• Lipid 44%
• Pharmacokinetics 21%
• Antiretroviral 20%
• Drug 18%
• Protease Inhibitor 16%
• Polydispersity 14%
• Bioavailability 13%
• Zeta Potential 12%
• Lopinavir 11%
• Area Under the Curve 10%
• Antiviral Drug 9%
• Alpha-Tocopherol 8%
• Excipient 7%
• Liquid 7%
• Suspension 5%
• Dose 5%
• Differential Scanning Calorimetry 5%
• Phosphate 4%
• Buffer Solution 4%
• Fourier Transform Infrared Spectroscopy 3%
• Purity 3%